ISTH 2021 Congress
Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » HIT
Theme Navigation
-
Abstract Number: PB0857
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin Induced Thrombocytopenia
-
Abstract Number: PB0863
A Puzzling HIT History: HIT Associated with Fondaparinux or True Autoimmune HIT?
-
Abstract Number: OC 47.2
A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-treated Frozen Platelets is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Implications for Development of a Near-patient HIT in vitro Diagnostic Assay
-
Abstract Number: PB0855
Diagnosing Heparin-induced Thrombocytopenia Using Machine Learning Algorithms: First Data of the TORADI-HIT Study
-
Abstract Number: PB0860
Incidence of Heparin Induced Thrombocytopenia 2009-2017: Analysis of the National Inpatient Sample Database
-
Abstract Number: PB0861
Incidence of Heparin-induced Thrombocytopenia in Patients Treated with Mechanical Circulatory Support: Results from a Prospective Study
-
Abstract Number: PB0856
Minimal Role of the Alternative Pathway in Complement Aactivation by HIT Immune Complexes
-
Abstract Number: PB0859
PF4/Polyanion ELISA-negative Antibodies to PF4 and Non-PF4 Targets Can Mediate Platelet Activation and Cause Heparin-induced Thrombocytopenia (HIT)
-
Abstract Number: OC 47.1
Prevention of Thrombocytopenia and Thrombosis in Heparin-induced Thrombocytopenia (HIT) Using Deglycosylated KKO: A Novel Therapeutic for HIT?
-
Abstract Number: PB0864
Successful Treatment with Edoxaban in Heparin-induced Thrombocytopenia with Thrombosis: A Case Report
-
Abstract Number: PB0862
Urgent Cardiac Surgery in a Patient with Heparin Induced Thrombocytopenia